These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results]. Oliw E; Wollheim FA Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877 [No Abstract] [Full Text] [Related]
4. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart]. MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204 [No Abstract] [Full Text] [Related]
5. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V; Hutchins B Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
7. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]
8. [Financial interests characterize published reports on coxiber. Whom can we rely on?]. HÃ¥kansson J Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746 [No Abstract] [Full Text] [Related]
9. Tailoring arthritis therapy in the wake of the NSAID crisis. Olsen NJ N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863 [No Abstract] [Full Text] [Related]
11. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Maetzel A; Krahn M; Naglie G Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781 [TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered]. MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036 [No Abstract] [Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update. van der Bijl P; van der Bijl P SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528 [No Abstract] [Full Text] [Related]
15. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases. Gibofsky A J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424 [TBL] [Abstract][Full Text] [Related]
16. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"]. MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601 [No Abstract] [Full Text] [Related]
17. Why don't we initiate more large simple randomized controlled trials? Wright JM CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653 [No Abstract] [Full Text] [Related]
18. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis. Wildy KS; Wasko MC Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054 [TBL] [Abstract][Full Text] [Related]
19. The COX-2 inhibitors--an update. Furberg CD Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896 [No Abstract] [Full Text] [Related]
20. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care. Wolfe F; Zhao S; Pettitt D J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]